Intelicare Holdings Inkomsten in het verleden

Verleden criteriumcontroles 0/6

De winst van Intelicare Holdings is gedaald met een gemiddeld jaarlijks percentage van -1.2%, terwijl de winst van de Healthcare Services -industrie jaarlijks groeide met 12.3%. De inkomsten zijn groeide met een gemiddeld percentage van 5.3% per jaar.

Belangrijke informatie

-1.2%

Groei van de winst

24.2%

Groei van de winst per aandeel

Healthcare Services Groei van de industrie	42.6%
Inkomstengroei	5.3%
Rendement op eigen vermogen	n/a
Nettomarge	-795.2%
Laatste winstupdate	30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Opbrengsten en kosten

Hoe Intelicare Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

CHIA:ICR Opbrengsten, kosten en inkomsten (AUD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven	R&D-uitgaven
30 Jun 24	0	-2	2	0
31 Mar 24	0	-2	2	0
31 Dec 23	0	-1	2	0
30 Sep 23	0	-2	2	0
30 Jun 23	0	-3	2	0
31 Mar 23	0	-4	2	0
31 Dec 22	0	-4	2	0
30 Sep 22	0	-4	2	0
30 Jun 22	0	-4	2	0
31 Mar 22	0	-4	3	0
31 Dec 21	0	-5	3	0
30 Sep 21	0	-5	3	0
30 Jun 21	0	-4	3	0
31 Mar 21	0	-3	2	0
31 Dec 20	1	-2	1	0
30 Sep 20	0	-2	1	0
30 Jun 20	0	-3	1	0
30 Jun 19	0	0	0	1
30 Jun 18	0	0	0	0

Kwaliteitswinsten: ICR is momenteel verliesgevend.

Groeiende winstmarge: ICR is momenteel verliesgevend.

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: ICR is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 1.2% per jaar.

Versnelling van de groei: Het is niet mogelijk om de winstgroei van ICR over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.

Winst versus industrie: ICR is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Healthcare Services industrie ( 21.3% ).

Rendement op eigen vermogen

Hoge ROE: De schulden van ICR zijn groter dan de activa, dus het is lastig om het rendement op het eigen vermogen te berekenen.

Intelicare Holdings Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Full year 2024 earnings released: AU$0.01 loss per share (vs AU$0.018 loss in FY 2023)

Full year 2023 earnings released: AU$0.018 loss per share (vs AU$0.038 loss in FY 2022)

First half 2023 earnings released: AU$0.018 loss per share (vs AU$0.02 loss in 1H 2022)

Full year 2022 earnings released: AU$0.038 loss per share (vs AU$0.058 loss in FY 2021)

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Full year 2021 earnings released: AU$0.058 loss per share (vs AU$0.06 loss in FY 2020)

Recent updates

Intelicare Holdings Limited, Annual General Meeting, Nov 29, 2024

Full year 2024 earnings released: AU$0.01 loss per share (vs AU$0.018 loss in FY 2023)

New major risk - Shareholder dilution

Intelicare Holdings Limited, Annual General Meeting, May 31, 2024

Less than half of directors are independent

New major risk - Financial position

Less than half of directors are independent

Less than half of directors are independent

Intelicare Holdings Limited has filed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Intelicare Holdings Limited has filed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Intelicare Holdings Limited has filed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Less than half of directors are independent

Intelicare Holdings Limited, Annual General Meeting, Nov 28, 2023

Less than half of directors are independent

Full year 2023 earnings released: AU$0.018 loss per share (vs AU$0.038 loss in FY 2022)

New minor risk - Financial data availability

Less than half of directors are independent

Less than half of directors are independent

InteliCare Holdings Ltd Announces Step Down of Scott Taylor as Non-Executive Director, Effective 13 June 2023

Less than half of directors are independent

Less than half of directors are independent

First half 2023 earnings released: AU$0.018 loss per share (vs AU$0.02 loss in 1H 2022)

Intelicare Holdings Limited Announces an Expansion of Their Services to Include Personal Emergency Response

Intelicare Holdings Limited, Annual General Meeting, Nov 29, 2022

Intelicare Holdings Limited Announces Director Changes

Full year 2022 earnings released: AU$0.038 loss per share (vs AU$0.058 loss in FY 2021)

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Intelicare Holdings Limited Announces Major Board Appointments and New Strategic Direction

Intelicare Holdings Limited Announces Executive Changes

Less than half of directors are independent

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

InteliCare Holdings Ltd Announces Board and Committee Changes

Full year 2021 earnings released: AU$0.058 loss per share (vs AU$0.06 loss in FY 2020)

Intelicare Holdings Limited announced that it expects to receive AUD 2.573 million in funding

InteliCare Holdings Ltd Announces Appointment of Gary Elwell of Gap Corporate Services as Chief Financial Officer

New 90-day high: AU$0.30

First half 2021 earnings released: AU$0.016 loss per share (vs AU$0.026 loss in 1H 2020)

InteliCare Holdings Ltd Signs Five Year Strategic Supply Agreement with Optus Networks Pty Ltd

New 90-day low: AU$0.23

Full year earnings released - AU$0.06 loss per share

Intelicare Holdings Limited Launches B2C Strategy with New Online Sales Platform and Ecommerce Marketplace

New 90-day low: AU$0.27

New 90-day low - AU$0.30

Opbrengsten en kosten

Inkomsten en omzetgeschiedenis

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Rendement op eigen vermogen

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden